Genpharmasec

  • Market Cap: Micro Cap
  • Industry: Trading & Distributors
  • ISIN: INE861N01036
  • NSEID:
  • BSEID: 531592
INR
1.02
-0.03 (-2.86%)
BSENSE

Oct 09

BSE+NSE Vol: 8.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
EQUITY AND LIABILITIES
No of Months
12
12
12
12
Share Capital
55.37
55.37
55.37
27.69
Share Warrants & Outstandings
Total Reserve
10.89
9.79
9.02
-12.36
Shareholder's Funds
66.26
65.16
64.40
15.33
Minority Interest
-0.62
0.12
0.14
0.00
Long-Term Borrowings
23.97
3.15
3.21
2.48
Secured Loans
0.00
0.00
0.00
0.00
Unsecured Loans
23.97
3.15
3.21
2.48
Deferred Tax Assets / Liabilities
-2.52
-0.46
-0.43
-0.85
Other Long Term Liabilities
1.37
1.62
0.68
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
Long Term Provisions
0.14
0.01
0.00
0.00
Total Non-Current Liabilities
22.96
4.31
3.46
1.64
Current Liabilities
Trade Payables
31.59
8.26
2.38
1.37
Other Current Liabilities
6.41
1.58
0.32
0.09
Short Term Borrowings
9.00
0.00
0.00
0.60
Short Term Provisions
0.03
0.00
0.00
0.00
Total Current Liabilities
47.03
9.84
2.70
2.06
Total Liabilities
135.64
79.43
70.70
19.03
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
Gross Block
47.84
8.48
0.93
0.15
Less: Accumulated Depreciation
6.59
0.89
0.10
0.05
Less : Impairment of Assets
0.00
0.00
0.00
0.00
Net Block
41.24
7.58
0.84
0.10
Lease Adjustment
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
Non Current Investments
1.58
19.73
17.64
0.00
Long Term Loans & Advances
11.75
23.69
11.25
0.00
Other Non Current Assets
0.54
2.00
0.00
0.00
Total Non-Current Assets
55.11
53.01
29.73
0.10
Current Assets Loans & Advances
Current Investments
0.00
0.00
1.68
0.95
Inventories
13.88
7.30
8.84
9.68
Sundry Debtors
29.27
13.60
9.10
5.71
Cash and Bank
10.07
5.27
18.83
1.99
Other Current Assets
1.22
0.04
0.43
0.03
Short Term Loans and Advances
26.09
0.21
2.09
0.57
Total Current Assets
80.52
26.42
40.97
18.93
Net Current Assets (Including Current Investments)
33.50
16.59
38.27
16.87
Total Current Assets Excluding Current Investments
80.52
26.42
39.29
17.98
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
Total Assets
135.64
79.43
70.70
19.03
Contingent Liabilities
0.00
0.00
0.00
0.00
Total Debt
32.98
3.15
3.21
3.08
Book Value per share (adjusted)
0
1.18
1.16
0.330707714509049
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 946.98% vs -1.87% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -15.43% vs 138.24% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 444.06% vs 802.38% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -91.99% vs 11.85% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 204.77% vs -35.51% in Mar 2025

Compare Balance Sheet Results of Genpharmasec
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
55.37
0
55.37
0.00%
Share Warrants & Outstandings
Total Reserve
10.89
0
10.89
0.00%
Shareholder's Funds
66.26
0
66.26
0.00%
Minority Interest
-0.62
0
-0.62
0.00%
Long-Term Borrowings
23.97
0
23.97
0.00%
Secured Loans
0.00
0
0.00
0.00%
Unsecured Loans
23.97
0
23.97
0.00%
Deferred Tax Assets / Liabilities
-2.52
0
-2.52
0.00%
Other Long Term Liabilities
1.37
0
1.37
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.14
0
0.14
0.00%
Total Non-Current Liabilities
22.96
0
22.96
0.00%
Current Liabilities
Trade Payables
31.59
0
31.59
0.00%
Other Current Liabilities
6.41
0
6.41
0.00%
Short Term Borrowings
9.00
0
9.00
0.00%
Short Term Provisions
0.03
0
0.03
0.00%
Total Current Liabilities
47.03
0
47.03
0.00%
Total Liabilities
135.64
0
135.64
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
47.84
0
47.84
0.00%
Less: Accumulated Depreciation
6.59
0
6.59
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
41.24
0
41.24
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
1.58
0
1.58
0.00%
Long Term Loans & Advances
11.75
0
11.75
0.00%
Other Non Current Assets
0.54
0
0.54
0.00%
Total Non-Current Assets
55.11
0
55.11
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
13.88
0
13.88
0.00%
Sundry Debtors
29.27
0
29.27
0.00%
Cash and Bank
10.07
0
10.07
0.00%
Other Current Assets
1.22
0
1.22
0.00%
Short Term Loans and Advances
26.09
0
26.09
0.00%
Total Current Assets
80.52
0
80.52
0.00%
Net Current Assets (Including Current Investments)
33.50
0
33.50
0.00%
Total Current Assets Excluding Current Investments
80.52
0
80.52
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
135.64
0
135.64
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
32.98
0
32.98
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 32.98 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 946.98% vs -1.87% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -15.43% vs 138.24% in Mar 2025

Annual - Fixed Assets
Fixed Assets 41.24 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 444.06% vs 802.38% in Mar 2025

Annual - Investments
Investments 1.58 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -91.99% vs 11.85% in Mar 2025

Annual - Current Assets
Current Assets 80.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 204.77% vs -35.51% in Mar 2025